HUS Heart and Lung Center achieved Magnet® recognition
25.7.2024 07:49:25 EEST | HUS | Press release
American Nurses Credentialing Center ANCC awarded HUS Heart and Lung Center the Magnet® recognition. The recognition proves that the quality of nursing, patient safety, and nurses’ job satisfaction in Heart and Lung Center are measured to be excellent both on a national and international level.
The esteemed Magnet® recognition is awarded to a hospital with high-quality nursing after a thorough evaluation. The recognition is awarded for four years at a time, and it benefits the patients, nursing staff, and the entire organization.
An achievement for Finnish nursing
The nurses working in a Magnet Hospital are committed professionals who are satisfied in their work.
“The Magnet recognition is a remarkable prize to the staff and supervisors for their long-term work on developing patient care and wellbeing at work. It is also a highly significant achievement for Finnish nursing”, says Chief Nursing Officer Virpi Sneck.
The development of nursing in Heart and Lung Center has been evidence-based, and new knowledge and innovations are constantly utilized. The nurses also participate in the decision-making process concerning their work.
Development provides significant savings
The long-term development work is evident in improved results in patient care and patient satisfaction, and also in nurse attraction that has increased for several years already.
“Our achievements also have a financial effect. Complications, such as pressure injuries or healthcare-associated infections cause major costs in addition to physical suffering of the patients. Our nursing has had a significant effect on reducing these complications,” explains Sneck.
Patient satisfaction in Heart and Lung Center has been among the highest at HUS for several years.
“The application process alone has increased our nurse attraction and retention. The positive effect is also seen in feedback from the patients”, says Mika Laine, Director of Heart and Lung Center.
Heart and Lung Center is the third hospital in Europe and the second in the Nordic Countries to achieve Magnet recognition. HUS Comprehensive Cancer Center was awarded the same recognition this spring.
Keywords
Contacts
HUS Magnet Program Director Marita Ritmala, marita.ritmala@hus.fi, tel. +358 50 309 5518
HUS Heart and Lung Center Chief Nursing Officer Virpi Sneck, virpi.sneck@hus.fi, tel. +358 50 428 7904
Director of HUS Heart and Lung Center Mika Laine mika.laine@hus.fi tel. +358 40 524 5735
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Studie gav ny kunskap om immunförsvaret vid leukemi29.9.2026 08:26:54 EEST | Pressmeddelande
Forskare vid HUS Cancercentrum och Helsingfors universitet utredde hur immunsystemet hos patienter med akut myeloisk leukemi reagerade på experimentell immunterapi. Förändringar som hänför sig till terapiresponsen visade sig i andra immunceller än förväntat baserat på tidigare studier.
Tutkimus toi uutta tietoa leukemian immuunipuolustuksesta29.9.2026 08:26:54 EEST | Tiedote
HUSin Syöpäkeskuksen ja Helsingin yliopiston tutkijat selvittivät, miten akuuttia myelooista leukemiaa sairastavien potilaiden immuunijärjestelmä reagoi kokeelliseen immunoterapiaan. Hoitovasteeseen liittyvät muutokset näkyivät eri immuunisoluissa kuin aiempien tutkimusten perusteella olisi voitu odottaa.
Study provides new insights into the immune response in leukemia29.9.2026 08:26:54 EEST | Press release
Researchers at HUS Comprehensive Cancer Center and the University of Helsinki investigated how the immune systems of patients with acute myeloid leukemia (AML) respond to experimental immunotherapy. The study found that changes associated with treatment response were observed in different immune cell types than would have been expected based on previous research.
Genetiska undersökningar kan avslöja orsaken till plötslig oförklarlig död hos unga14.9.2026 09:18:15 EEST | Pressmeddelande
Den bakomliggande orsaken till plötslig oförklarlig död hos unga kan vara en sällsynt ärftlig sjukdom som nödvändigtvis inte kommer fram i vanliga undersökningar. Genetiska undersökningar är en viktig del särskilt i utredningen av plötsliga oväntade dödsfall hos unga. Genetiska undersökningar kan också bidra till att identifiera släktingar som omfattas av risken och förebygga eventuella allvarliga hjärthändelser.
Geenitutkimus voi paljastaa syyn nuoren selittämättömälle äkkikuolemalle14.9.2026 09:18:15 EEST | Tiedote
Nuoren selittämättömän äkkikuoleman taustalla voi olla harvinainen perinnöllinen sairaus, joka ei välttämättä tule esiin tavanomaisissa tutkimuksissa. Geenitutkimus on tärkeä osa erityisesti nuorten odottamattomien äkkikuolemien syyn selvittämisessä. Geenitutkimus voi myös auttaa tunnistamaan riskissä olevia sukulaisia ja ehkäistä mahdollisia vakavia sydäntapahtumia.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom